Double-reverse: FDA now says it will review Moderna’s mRNA flu vaccine | CIDRAP

[nedhamson1@mastodon.social]

Double-reverse: FDA now says it will review Moderna’s mRNA flu vaccine | CIDRAP

One week after saying it was refusing to review Moderna’s application for approval of a new flu vaccine, the US Food and Drug Administration's (FDA’s) Center for Biologics Evaluation and Research (CBER) has reversed course and will review the application for an mRNA flu vaccine for those 50 and older. Before the initial reversal, the FDA previously indicated support for the company’s phase…

Double-reverse: FDA now says it will review Moderna’s mRNA flu vaccine | CIDRAP

One week after saying it was refusing to review Moderna’s application for approval of a new flu vaccine, the US Food and Drug Administration's (FDA’s) Center for Biologics Evaluation and Research (CBER) has reversed course and will review the application for an mRNA flu vaccine for those 50 and older. Before the initial reversal, the FDA previously…

Ned Hamson's Second Line View of the News (nedhamsonsecondlineviewofthenews.com)